17 / 54
16
Tradelink Electronic Commerce Limited
貿易通電子貿易有限公司
Disclosure of Directors’ and Chief Executive’s Interests
(Continued)
董事及行政總裁的權益披露
（續）
The Board has the absolute discretion to offer any employees (whether full
or part-time), directors (including Independent Non-executive Directors),
consultants, business associates or advisers of the Company or any company
within the Group options to subscribe for shares, provided that the total number
of shares issued or to be issued to any one grantee in any 12-month period
shall not exceed 1% of the shares of the Company in issue. The grantee shall
pay HK$1.00 to the Company as nominal consideration for the grant upon
acceptance of the offer of an option. Each option has a 10-year exercise
period.
The subscription amount payable in respect of each share option upon exercise
of an option shall be determined by the Board and shall be not less than the
greater of:
(i) the closing price of the shares on the SEHK’s daily quotation sheet on the
date, which must be a business day, of a written offer of such option (the
“Date of Grant”); and
(ii) the average closing price of the shares on the SEHK as stated in the SEHK’s
daily quotation sheets for the five business days immediately preceding the
Date of Grant.
At Board meeting on 24 June 2014, the Board approved an allotment of
share options under the Share Option Scheme 2014 to certain individuals (the
“Grantees”) entitling them to subscribe for a total of 12,200,000 ordinary
shares of the Company. The terms are the same as those stated above.
Commencing from the first, second, third and fourth anniversaries of the grant of
the option, the relevant Grantee may exercise up to 25%, 50%, 75% and 100%
respectively of the shares comprised in the option (less any number of shares in
respect of which the option has been previously exercised).
At the Annual General Meeting of the Company on 8 May 2015, shareholders
approved the amendments to clauses 10.1(D), 10.1(E) and 2.1 of the Share
Options Scheme 2014. Such amendments to the Share Options Scheme 2014
give the Board a discretion to waive or extend the 90-day Limitation with
authority to impose conditions to any such waiver or extension and to provide an
appropriate exercise period for each grant of options during the Scheme Period.
This provides the Board with the necessary flexibility it needs to deal, in the best
interest of the Company, with the different types of situations that may arise over
the course of the ten-year validity period of the Scheme.
As at 30 June 2015, details of Directors’ and Chief Executive’s interests in
options to subscribe for shares of the Company granted under the Post-IPO
Share Option Scheme and the Share Option Scheme 2014 of the Company
are set out in the table below. Each option gives the holder the right to subscribe
for one ordinary share of the Company.
董事會可全權酌情向本公司或本集團旗下任何公司的任何僱
員（不論全職或兼職）、董事（包括獨立非執行董事）、專業顧
問、業務夥伴或諮詢顧問授出可認購股份的購股權，惟於任
何十二個月內已發行或將發行予任何一名承授人的股份總數
不得超過本公司已發行股份的
1%
。接納購股權要約時，承
授人須向本公司支付港幣
1.00
元，作為獲授購股權的象徵
式代價。每份購股權的行使期均為十年。
因行使購股權而須就每份購股權支付的認購款項，將由董事
會釐定，且不得低於下列各項中的較高者：
(i)
於購股權的書面要約日期（「授出日期」，必須為營業
日），於香港聯交所每日報價表所列股份的收市價；及
(ii)
緊接授出日期前五個營業日，於香港聯交所每日報價
表所列股份在香港聯交所的平均收市價。
董事會於二零一四年六月二十四日舉行的董事會議上，批准
根據二零一四年購股權計劃向若干個人（「承授人」）配發購股
權，彼等可據以認購合共
12,200,000
股本公司普通股，有
關條款與上文所述者相同。由獲授購股權之日起計第一、第
二、第三及第四週年開始，有關承授人可分別行使購股權認
購不超過
25%
、
50%
、
75%
及
100%
的所涉股份（減去過往已
行使的購股權所涉及的股份數目）。
股東於二零一五年五月八日舉行的本公司股東週年大會上，
批准修訂二零一四年購股權計劃之第
10.1(D)
、
10.1(E)
及
2.1
條條款。修訂二零一四年購股權計劃授權董事會酌情豁免或
延長
90
日限制，並規定豁免或延期的相應條件以及計劃期
間內所授各項購股權適用的行使期。此舉可讓董事會以符合
本公司最佳利益的方式靈活處理計劃十年有效期間可能發生
的各類情況。
於二零一五年六月三十日，董事及行政總裁於認購本公司根
據首次公開招股後購股權計劃及二零一四年購股權計劃所授
股份的購股權中擁有的權益詳情載於下表。每份購股權賦予
其持有人認購一股本公司普通股的權利。